2015年默克雪兰诺中国生殖医学研究基金CREATE标书征集火热进行中

2015-01-21 MedSci MedSci原创

2015年默克雪兰诺中国生殖医学研究基金CREATE标书征集火热进行中······ 默克雪兰诺中国生殖医学研究基金(MerckSerono China Research Fund for Fertility Experts，简称CREATE)由默克雪兰诺有限公司于2014年3月正式设立，旨在鼓励中国优秀中、青年学者开展针对生殖医学的临床研究(Clinical Research)及转化型医学研

默克雪兰诺中国生殖医学研究基金(MerckSerono China Research Fund for Fertility Experts，简称CREATE)由默克雪兰诺有限公司于2014年3月正式设立，旨在鼓励中国优秀中、青年学者开展针对生殖医学的临床研究(Clinical Research)及转化型医学研究(Translational Research)，促进对不孕症治疗的深入研究，增进生殖医学专业工作者之间的研究合作与学术交流。宗旨是改善辅助生殖治疗的结局，并最终提高活产率。

CREATE基金自2014年3月正式启动以来，得到了生殖领域诸多学者的积极参与和热烈反馈，在2014年共收到108份申请方案，经过严格的评审，最终有17份研究方案获得CREATE基金资助。
2015年CREATE基金的申请工作已于2014年11月22日正式启动，申请者请登陆CREATE基金官方网站（https://www.medsci.cn/merckserono_create/）在线提交申请书，申请时间为2014年11月22日至2015年3月31日。为了保证CREATE基金评审过程公平、公正，所有的CREATE基金申请书都将由独立第三方设盲后，再交由CREATE基金委的评审专家进行评审，最终评选结果将于2015年6月30日后公布。谢谢大家关注！

另附：2014年CREATE基金颁奖活动介绍

2014年11月22日，默克雪兰诺公司在昆明临床学组会议上举办了CREATE基金颁奖典礼，获得CREATE基金资助的17位研究者出席了颁奖典礼。颁奖典礼由默克雪兰诺医学事务部生殖医学团队负责人房文辉先生主持，中山大学附属第一医院周灿权教授作为CREATE基金专家评审代表作了致辞。周教授在致辞中表示：默克雪兰诺公司作为全球辅助生殖领域中的产品引领者，不仅关注产品销售，而且更加关注企业社会责任，积极推动生殖医学领域学术发展和中、青年医生成长。CREATE项目的设立为大家提供了学术交流的新平台，希望生殖领域中、青年医生能够积极关注CREATE项目，保持研究热情在2015年的基金申请中有所斩获！

默克雪兰诺医学事务部生殖医学团队负责人房文辉先生致辞

中山大学附属第一医院周灿权教授致辞

颁奖环节中，周灿权教授、朱桂金教授、何方方教授、于修成教授、庄广伦教授以及默克雪兰诺生殖领域负责人作为颁奖嘉宾为17名获奖者颁发了奖杯。

颁奖嘉宾为2014年CREATE基金获奖老师颁奖

会后获奖医生与颁奖嘉宾合影留念并表示非常感谢默克雪兰诺公司为促生殖医学领域学术研究做出的贡献；今后将持续关注CREATE项目，积极提高自身科研水平推动领域发展。

2014年CREATE基金获奖老师与颁奖嘉宾合影

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-03-05 风铃821

#默克雪兰诺#

31 0
[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-08-06 hlycom3356

表示支持的

100 0
[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-08-06 hlycom3356

希望这种活动多多

116 0
[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-10-18 fusion

#生殖医学#

44 0
[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-01-23 makuansheng

#默克#

30 0
[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-01-23 chenshujs

#标书#

41 0
[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-01-23 ms1065684921169360

#医学研究#

37 0
[GetPortalCommentsPageByObjectIdResponse(id=1992007, encodeId=2158199200e03, content=<a href='/topic/show?id=eae710335997' target=_blank style='color:#2F92EE;'>#默克雪兰诺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103359, encryptionId=eae710335997, topicName=默克雪兰诺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Mar 05 04:07:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34937, encodeId=707d3493eb0, content=表示支持的, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34938, encodeId=b2a43493852, content=希望这种活动多多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 21:45:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775976, encodeId=e7201e75976c3, content=<a href='/topic/show?id=ff0b690e069' target=_blank style='color:#2F92EE;'>#生殖医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69070, encryptionId=ff0b690e069, topicName=生殖医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98138855513, createdName=fusion, createdTime=Sun Oct 18 03:07:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273876, encodeId=469f12e387649, content=<a href='/topic/show?id=4909103353c5' target=_blank style='color:#2F92EE;'>#默克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103353, encryptionId=4909103353c5, topicName=默克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495724, encodeId=1a501495e24f2, content=<a href='/topic/show?id=3c4161912a4' target=_blank style='color:#2F92EE;'>#标书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61912, encryptionId=3c4161912a4, topicName=标书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ea09191365, createdName=chenshujs, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543592, encodeId=069a1543592be, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581449, encodeId=c4641581449af, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Fri Jan 23 00:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
2015-01-23 HinsMax

#CRE#

42 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

妇产科

2015年默克雪兰诺中国生殖医学研究基金CREATE标书征集火热进行中

相关资讯

科室

工具

服务

妇产科

2015年默克雪兰诺中国生殖医学研究基金CREATE标书征集火热进行中

相关资讯

默克雪兰诺携手CSCO宣布全新合作项目，推动中国肿瘤领域创新

科室

工具

服务